Form 4: Myomo Inc. Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports acquisition and disposal of common stock, including a sale to cover income taxes on vested restricted stock units.
Summary
- On March 11, 2025, Harry Kovelman, Chief Medical Officer of Myomo, Inc., was granted 3,553 restricted stock units (RSUs) which vested immediately.
- On March 12, 2025, Kovelman sold 30,000 shares of common stock in the open market at an average price of $5.5006 per share.
- On March 13, 2025, Kovelman sold 1,496 shares to cover income taxes related to the vesting of the RSUs on March 11, 2025.
- Following these transactions, Kovelman beneficially owns 96,477 shares of Myomo, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. There is no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the amounts are relatively small.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Grant of 3,553 restricted stock units (RSUs) which vested immediately. |
| 03/12/2025 | Sale of 30,000 shares of common stock at an average price of $5.5006 per share. |
| 03/13/2025 | Sale of 1,496 shares to cover income taxes on vested RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.